Path’s HPV Trials in India: Troubling Questions

[SaneVax: The questions Professor Allyson Pollock discusses with Newsclick regarding the Path sponsored Human Pappilomavirus Vaccine trials in Gujarat and Andhra Pradesh are the same questions every government in the world should be asking. She brings up many troubling issues raised by such trials, not just the more controversial one surrounding the lack of informed consent. Questions pertaining to  efficacy of HPV vaccines, the cost, and the health prioritities a country such as India should have. These questions are important for any country,  particularly when multiple  new vaccines being promoted by pharmaceutical companies.]

 

Speak Your Mind

*

*